These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
678 related items for PubMed ID: 9126968
1. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. Giordano V, De Falco G, Chiari R, Quinto I, Pelicci PG, Bartholomew L, Delmastro P, Gadina M, Scala G. J Immunol; 1997 May 01; 158(9):4097-103. PubMed ID: 9126968 [Abstract] [Full Text] [Related]
2. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Schaper F, Gendo C, Eck M, Schmitz J, Grimm C, Anhuf D, Kerr IM, Heinrich PC. Biochem J; 1998 Nov 01; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795 [Abstract] [Full Text] [Related]
3. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Kim H, Baumann H. Mol Cell Biol; 1999 Aug 01; 19(8):5326-38. PubMed ID: 10409724 [Abstract] [Full Text] [Related]
4. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, Anderson KC. J Immunol; 1997 Sep 01; 159(5):2212-21. PubMed ID: 9278309 [Abstract] [Full Text] [Related]
5. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex. Bode JG, Schweigart J, Kehrmann J, Ehlting C, Schaper F, Heinrich PC, Häussinger D. J Immunol; 2003 Jul 01; 171(1):257-66. PubMed ID: 12817006 [Abstract] [Full Text] [Related]
6. Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line. Kumar G, Gupta S, Wang S, Nel AE. J Immunol; 1994 Nov 15; 153(10):4436-47. PubMed ID: 7963520 [Abstract] [Full Text] [Related]
8. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP, Hügl SR, Myers MG, White MF, Reifel-Miller A, Rhodes CJ. Biochem J; 1999 Dec 15; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [Abstract] [Full Text] [Related]
9. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I. J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060 [Abstract] [Full Text] [Related]
10. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Majka M, Ratajczak J, Villaire G, Kubiczek K, Marquez LA, Janowska-Wieczorek A, Ratajczak MZ. Exp Hematol; 2002 Jul 15; 30(7):751-60. PubMed ID: 12135673 [Abstract] [Full Text] [Related]
11. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, Bistrian BR, Smith RJ. Endocrinology; 1996 Jul 15; 137(7):2880-6. PubMed ID: 8770909 [Abstract] [Full Text] [Related]
12. Interleukin 5 signals through Shc and Grb2 in human eosinophils. Bates ME, Busse WW, Bertics PJ. Am J Respir Cell Mol Biol; 1998 Jan 15; 18(1):75-83. PubMed ID: 9448048 [Abstract] [Full Text] [Related]
13. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H. J Biol Chem; 2000 Aug 18; 275(33):25273-85. PubMed ID: 10854424 [Abstract] [Full Text] [Related]
14. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor. Smit L, van der Horst G, Borst J. Oncogene; 1996 Jul 18; 13(2):381-9. PubMed ID: 8710377 [Abstract] [Full Text] [Related]
15. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Thirone AC, Carvalho CR, Saad MJ. Endocrinology; 1999 Jan 18; 140(1):55-62. PubMed ID: 9886807 [Abstract] [Full Text] [Related]
16. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules. Nakamura T, Komiya M, Gotoh N, Koizumi S, Shibuya M, Mori N. Oncogene; 2002 Jan 03; 21(1):22-31. PubMed ID: 11791173 [Abstract] [Full Text] [Related]
17. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1. Neumann C, Zehentmaier G, Danhauser-Riedl S, Emmerich B, Hallek M. Eur J Immunol; 1996 Feb 03; 26(2):379-84. PubMed ID: 8617307 [Abstract] [Full Text] [Related]
18. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? Sriram K, Benkovic SA, Hebert MA, Miller DB, O'Callaghan JP. J Biol Chem; 2004 May 07; 279(19):19936-47. PubMed ID: 14996842 [Abstract] [Full Text] [Related]
19. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K, Kishimoto T. Circulation; 1996 Nov 15; 94(10):2626-32. PubMed ID: 8921810 [Abstract] [Full Text] [Related]
20. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase. Park RK, Erdreich-Epstein A, Liu M, Izadi KD, Durden DL. J Immunol; 1999 Dec 01; 163(11):6023-34. PubMed ID: 10570290 [Abstract] [Full Text] [Related] Page: [Next] [New Search]